Thomas Steyer’s Medline Inc MDLN Stock Holding History

Thomas Steyer’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-260,000	Closed	-$10.9M	–	204
2025 Q4	$10.9M	Buy	+260,000	New	+$11M	0.05%	73

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $2.8B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Thomas Steyer's MDLN Position: Q1 2026 in Review

Thomas Steyer sold out of Medline Inc (MDLN) in Q1 2026, closing a stake of 260,000 shares — an estimated $10.9M sold.

Thomas Steyer first reported a position in MDLN in Q4 2025 and held it in 1 quarter. The position peaked at $10.9M in Q4 2025. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

Thomas Steyer reported no remaining Medline Inc position as of Q1 2026 after selling out during the quarter.
Thomas Steyer sold 260,000 Medline Inc shares in Q1 2026, an estimated $10.9M.
Thomas Steyer first reported a position in Medline Inc in Q4 2025 and held it in 1 quarter.
Thomas Steyer's Medline Inc position peaked at $10.9M in Q4 2025.
314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Farallon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.